Xenon Pharmaceuticals Inc.

Ownership Transactions Reported by 19 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	0
Sells	5	-54.8 K	100%	$42.08	-$2.31 M
Net	-5	-54.8 K	-100%		-$2.31 M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Michael R. Hayden	Director	$3.18 M			Jun 3, 2021
Frank A. Holler	Director	$1.43 M			May 27, 2021
Michael M. Tarnow	Director	$768 K			May 18, 2021
Mohammad Azab	Director	$731 K			Dec 19, 2023
Ian Mortimer	PRESIDENT & CEO, Director	$449 K			Mar 11, 2024
Sherrington Robin	EVP, Strategy & Innovation	$389 K	-$330 K	-45.9%	Mar 11, 2024
Gary Patou	Director	$280 K	-$312 K	-52.7%	Jun 5, 2024
Dawn Svoronos	Director	$246 K	-$968 K	-79.7%	Jun 5, 2024
Steven Gannon	Director	$92.4 K	-$602 K	-86.7%	Jun 5, 2024
Simon N. Pimstone	Director	$59.1 K			Jun 2, 2023
Elizabeth A. Garofalo	Director	$0	-$95.6 K	-100%	Jun 5, 2024
Patrick Machado	Director				Jun 5, 2024
Sherry Aulin	Chief Financial Officer				Mar 11, 2024
Justin D. Gover	Director				Jun 5, 2024
Gillian Cannon	Director				Jun 5, 2024
Christopher John Kenney	Chief Medical Officer				Mar 11, 2024
Christopher Von Seggern	Chief Commercial Officer				Mar 11, 2024
James R. Empfield	EVP, Drug Discovery				Mar 11, 2024
Andrea DiFabio	Chief Legal Officer				Mar 11, 2024

Insider	Class	Transaction	%	Value $	Price $	Shares	Shares Owned	Date	Ownership